Ligo Biosciences Analysis: $0.1M Raised
What is Ligo Biosciences?
Ligo Biosciences specializes in developing generative models to design new enzymes for industrial use. Their approach leverages artificial intelligence to create enzymes that are not typically found in nature, addressing specific industrial needs. This innovation enables the production of pharmaceuticals, the breakdown of toxins, and the creation of fine chemicals.
HQ Country
San Francisco, United States
Employees
1-10
Founded
2024
Industry
AI/ML, Biotech
Product Features & Capabilities
- Generative models for enzyme design
- AI algorithms for protein engineering
- High throughput screening methodologies
- Custom enzyme solutions for pharmaceuticals
- Environmental toxin degradation technologies
How much Ligo Biosciences raised
Pre-Seed - N/A
September 25, 2024Lead Investor: Y Combinator, Liquid 2 Ventures, Oxonian Ventures
Seed - $125,000
August 2024Lead Investor: Y Combinator
M&A Offer - N/A
April 10, 2025Lead Investor: Not specified
